Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Blood
|
January 8, 2013
The CD300 molecules: an emerging family of regulators of the immune system
Francisco Borrego
Journal of Immunology (Baltimore, Md. : 1950)
|
October 24, 2006
The first molecular basis of the "missing self" hypothesis
Francisco Borrego
Experientia Supplementum (2012)
|
February 15, 2022
Role of NK Cells in Tumor Progression
Iñigo Terrén, Francisco Borrego
Frontiers in Immunology
|
July 23, 2016
Editorial: NK Cell-Based Cancer Immunotherapy
Francisco Borrego, Susana Larrucea, Rafael Solana, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 2016
Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells
Huifang Li, Francisco Borrego, Satoshi Nagata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2016
Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma
Olatz Zenarruzabeitia, Joana Vitallé, Itziar Astigarraga, et al.
Traffic (Copenhagen, Denmark)
|
September 2, 2009
Endocytosis and intracellular trafficking of human natural killer cell receptors
Madhan Masilamani, Giovanna Peruzzi, Francisco Borrego, et al.
Immunologic Research
|
November 4, 2008
Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A
Giovanna Peruzzi, Madhan Masilamani, Francisco Borrego, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2002
Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal
Juraj Kabat, Francisco Borrego, Andrew Brooks, et al.
Scientific Reports
|
April 5, 2016
CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition
Milena Dimitrova, Olatz Zenarruzabeitia, Francisco Borrego, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Blood
|
January 8, 2013
The CD300 molecules: an emerging family of regulators of the immune system
Francisco Borrego
Journal of Immunology (Baltimore, Md. : 1950)
|
October 24, 2006
The first molecular basis of the "missing self" hypothesis
Francisco Borrego
Experientia Supplementum (2012)
|
February 15, 2022
Role of NK Cells in Tumor Progression
Iñigo Terrén, Francisco Borrego
Frontiers in Immunology
|
July 23, 2016
Editorial: NK Cell-Based Cancer Immunotherapy
Francisco Borrego, Susana Larrucea, Rafael Solana, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 2016
Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells
Huifang Li, Francisco Borrego, Satoshi Nagata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2016
Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma
Olatz Zenarruzabeitia, Joana Vitallé, Itziar Astigarraga, et al.
Traffic (Copenhagen, Denmark)
|
September 2, 2009
Endocytosis and intracellular trafficking of human natural killer cell receptors
Madhan Masilamani, Giovanna Peruzzi, Francisco Borrego, et al.
Immunologic Research
|
November 4, 2008
Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A
Giovanna Peruzzi, Madhan Masilamani, Francisco Borrego, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 8, 2002
Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal
Juraj Kabat, Francisco Borrego, Andrew Brooks, et al.
Scientific Reports
|
April 5, 2016
CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition
Milena Dimitrova, Olatz Zenarruzabeitia, Francisco Borrego, et al.
Page
of 11